Ortataxel is a drug used in chemotherapy.

As of June 2009[update], Spectrum Pharmaceuticals has the drug in a Phase 2 clinical trial.

[1]

This antineoplastic or immunomodulatory drug article is a stub.

You can help Wikipedia by expanding it.